
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Saccharomyces boulardii Ameliorates Dextran Sulfate Sodium‐Induced Ulcerative Colitis in Mice by Regulating NF‐κB and Nrf2 Signaling Pathways
Hui Gao, Yinzheng Li, Jie Sun, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 28
Hui Gao, Yinzheng Li, Jie Sun, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis
Mairead K. Heavey, Anthony Hazelton, Yuyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Mairead K. Heavey, Anthony Hazelton, Yuyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model
Tao Zhang, Weiqin Zhang, Cuijiao Feng, et al.
npj Science of Food (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 58
Tao Zhang, Weiqin Zhang, Cuijiao Feng, et al.
npj Science of Food (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 58
The comparative anti-oxidant and anti-inflammatory efficacy of postbiotics and probiotics through Nrf-2 and NF-kB pathways in DSS-induced colitis model
Niloofar Rezaie, Shadi Aghamohammad, Elham Haj Agha Gholizadeh Khiavi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Niloofar Rezaie, Shadi Aghamohammad, Elham Haj Agha Gholizadeh Khiavi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia
Ruoyu Wang, Mairepaiti Halimulati, Xiaojie Huang, et al.
Journal of Advanced Research (2022) Vol. 52, pp. 19-28
Open Access | Times Cited: 35
Ruoyu Wang, Mairepaiti Halimulati, Xiaojie Huang, et al.
Journal of Advanced Research (2022) Vol. 52, pp. 19-28
Open Access | Times Cited: 35
Both Saccharomyces boulardii and Its Postbiotics Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, Association with Modulating Inflammation and Intestinal Microbiota
Xinge Xu, Jingwei Wu, Yuxin Jin, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1484-1484
Open Access | Times Cited: 22
Xinge Xu, Jingwei Wu, Yuxin Jin, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1484-1484
Open Access | Times Cited: 22
Effects of Medicinal Plants and Phytochemicals in Nrf2 Pathways during Inflammatory Bowel Diseases and Related Colorectal Cancer: A Comprehensive Review
Lucas Fornari Laurindo, Mariana Canevari de Maio, Giulia Minniti, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 243-243
Open Access | Times Cited: 21
Lucas Fornari Laurindo, Mariana Canevari de Maio, Giulia Minniti, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 243-243
Open Access | Times Cited: 21
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Dan Linetzky Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 901-914
Open Access | Times Cited: 6
Dan Linetzky Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 901-914
Open Access | Times Cited: 6
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
Shuo Yuan, Qi Wang, Jiao Li, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 27
Shuo Yuan, Qi Wang, Jiao Li, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 27
Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease
Botong Li, Yixuan Wang, Xiaolin Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114950-114950
Open Access | Times Cited: 14
Botong Li, Yixuan Wang, Xiaolin Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114950-114950
Open Access | Times Cited: 14
Anti-Inflammatory, Barrier Maintenance, and Gut Microbiome Modulation Effects of Saccharomyces cerevisiae QHNLD8L1 on DSS-Induced Ulcerative Colitis in Mice
Qianjue Hu, Leilei Yu, Qixiao Zhai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6721-6721
Open Access | Times Cited: 13
Qianjue Hu, Leilei Yu, Qixiao Zhai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6721-6721
Open Access | Times Cited: 13
The preventive effects of Saccharomyces boulardii against oxidative stress induced by lipopolysaccharide in rat brain
Fatemeh Babaei, Ava Navidi-Moghaddam, Ariyan Naderi, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30426-e30426
Open Access | Times Cited: 5
Fatemeh Babaei, Ava Navidi-Moghaddam, Ariyan Naderi, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30426-e30426
Open Access | Times Cited: 5
Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study
Zejin Liu, Xinli Niu, Junpeng Wang
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 32, pp. 11026-11043
Closed Access | Times Cited: 20
Zejin Liu, Xinli Niu, Junpeng Wang
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 32, pp. 11026-11043
Closed Access | Times Cited: 20
The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial Myofibroblasts
Gesthimani Tarapatzi, Eirini Filidou, Leonidas Kandilogiannakis, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1293-1293
Open Access | Times Cited: 19
Gesthimani Tarapatzi, Eirini Filidou, Leonidas Kandilogiannakis, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1293-1293
Open Access | Times Cited: 19
Saccharomyces boulardii alleviates allergic asthma by restoring gut microbiota and metabolic homeostasis via up-regulation of METTL3 in an m6A-dependent manner
Da Liu, Lang Hu, Yue Yang, et al.
Immunology Letters (2024) Vol. 267, pp. 106853-106853
Closed Access | Times Cited: 4
Da Liu, Lang Hu, Yue Yang, et al.
Immunology Letters (2024) Vol. 267, pp. 106853-106853
Closed Access | Times Cited: 4
Intervention with fructooligosaccharides, Saccharomyces boulardii, and their combination in a colitis mouse model
Yan Wu, Hao Fu, Hao Fu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
Yan Wu, Hao Fu, Hao Fu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
A novel probiotic formula, BLLL, ameliorates chronic stress-induced depression-like behaviors in mice by reducing neuroinflammation and increasing neurotrophic factors
Minxiu Ye, Feng Ji, Chao Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Minxiu Ye, Feng Ji, Chao Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Development of a High-Cell-Density Production Process for a Biotherapeutic Yeast, Saccharomyces cerevisiae var. boulardii, for Use as a Human Probiotic
Ghaneshree Moonsamy, Sarisha Singh, Yrielle Roets-Dlamini, et al.
Fermentation (2025) Vol. 11, Iss. 4, pp. 186-186
Open Access
Ghaneshree Moonsamy, Sarisha Singh, Yrielle Roets-Dlamini, et al.
Fermentation (2025) Vol. 11, Iss. 4, pp. 186-186
Open Access
Collagen Peptides and Saccharomyces boulardiiCNCM I‐745 Attenuate Acetic Acid‐Induced Colitis in Rats by Modulating Inflammation and Barrier Permeability
Öykü Altınok, Murat Baş, Elif Gelenli Dolanbay, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 4
Open Access
Öykü Altınok, Murat Baş, Elif Gelenli Dolanbay, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 4
Open Access
Prevention of DSS-induced colitis in mice with water kefir microbiotaviaanti-inflammatory and microbiota-balancing activity
Zhimin Ye, Ximiao Yang, Boxiong Deng, et al.
Food & Function (2023) Vol. 14, Iss. 15, pp. 6813-6827
Closed Access | Times Cited: 9
Zhimin Ye, Ximiao Yang, Boxiong Deng, et al.
Food & Function (2023) Vol. 14, Iss. 15, pp. 6813-6827
Closed Access | Times Cited: 9
Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis
Yu Hu, Zhen Ye, Yingqi She, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Yu Hu, Zhen Ye, Yingqi She, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Use of Saccharomyces boulardii CNCM I‐745 as therapeutic strategy for prevention of nonsteroidal anti‐inflammatory drug‐induced intestinal injury
Vanessa D’Antongiovanni, Luca Antonioli, Laura Benvenuti, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 24, pp. 3215-3233
Open Access | Times Cited: 7
Vanessa D’Antongiovanni, Luca Antonioli, Laura Benvenuti, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 24, pp. 3215-3233
Open Access | Times Cited: 7
Antioxidant and anti-inflammatory properties of yeasts fermented passion fruit and soursop pulps: A focus on bioactive volatile compounds profile
Beatriz Itzel Martínez-Mendoza, Audry Peredo-Lovillo, Haydee Eliza Romero-Luna, et al.
Food Bioscience (2023) Vol. 56, pp. 103112-103112
Closed Access | Times Cited: 7
Beatriz Itzel Martínez-Mendoza, Audry Peredo-Lovillo, Haydee Eliza Romero-Luna, et al.
Food Bioscience (2023) Vol. 56, pp. 103112-103112
Closed Access | Times Cited: 7
Novel Dairy Fermentates Have Differential Effects on Key Immune Responses Associated with Viral Immunity and Inflammation
Dearbhla Finnegan, Mónica A. Mechoud, Claire Connolly, et al.
(2024)
Open Access | Times Cited: 2
Dearbhla Finnegan, Mónica A. Mechoud, Claire Connolly, et al.
(2024)
Open Access | Times Cited: 2
A Saccharomyces boulardii-derived antioxidant protein, thioredoxin, ameliorates intestinal inflammation through transactivating epidermal growth factor receptor
Xiali Qin, Qing Zhao, Qianjing Zhao, et al.
Pharmacological Research (2024) Vol. 208, pp. 107372-107372
Open Access | Times Cited: 2
Xiali Qin, Qing Zhao, Qianjing Zhao, et al.
Pharmacological Research (2024) Vol. 208, pp. 107372-107372
Open Access | Times Cited: 2
Preclinical evidence of probiotics in ulcerative colitis: a systematic review and network meta-analysis
Wenqin Jin, Huangping Ai, Qingqing Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Wenqin Jin, Huangping Ai, Qingqing Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6